For: | Chang J, Liu Y, Zhang DD, Zhang DJ, Wu CT, Wang LS, Cui CP. Hepatopoietin Cn suppresses apoptosis of human hepatocellular carcinoma cells by up-regulating myeloid cell leukemia-1. World J Gastroenterol 2010; 16(2): 193-200 [PMID: 20066738 DOI: 10.3748/wjg.v16.i2.193] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i2/193.htm |
Number | Citing Articles |
1 |
Na Li, Feng-Jiao Liu, Dan-Dan Li, Chun-Xia Sun, Jian Li, Mei-Hua Qu, Chun-Ping Cui, Da-Jin Zhang. Hepatopoietin Cn (HPPCn) Generates Protective Effects on Acute Liver Injury. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00646
|
2 |
Yang Liu, Saiyan Saiyan, Tong‐Yi Men, Hui‐Ying Gao, Chuan Wen, Yong Liu, Xu Zhou, Chu‐Tse Wu, Li‐Sheng Wang, Chun‐Ping Cui. Hepatopoietin Cn reduces ethanol‐induced hepatoxicity via sphingosine kinase 1 and sphingosine 1‐phosphate receptors. The Journal of Pathology 2013; 230(4): 365 doi: 10.1002/path.4194
|
3 |
Mengmeng Yu, Yuxing Qu, Haili Zhang, Xiaojun Wang. Roles of ANP32 proteins in cell biology and viral replication. Animal Diseases 2022; 2(1) doi: 10.1186/s44149-022-00055-7
|
4 |
Linda A. Heffernan-Stroud, Lina M. Obeid. The Role of Sphingolipids in Cancer Development and Therapy. Advances in Cancer Research 2013; 117: 201 doi: 10.1016/B978-0-12-394274-6.00007-8
|
5 |
Bu-Dong Zhu, Xiao-Li Li, Yong Liu, Jing Chang, Yang Liu, Dong-Dong Zhang, Qiang Wang, Jun Ren, Chun-Ping Cui. Involvement of Hepatopoietin Cn in the development of human hepatocellular carcinoma. Clinical & Experimental Metastasis 2010; 27(8): 571 doi: 10.1007/s10585-010-9346-8
|
6 |
Kyu Min Kim, Eun Jin Shin, Ji Hye Yang, Sung Hwan Ki. Integrative roles of sphingosine kinase in liver pathophysiology. Toxicological Research 2023; 39(4): 549 doi: 10.1007/s43188-023-00193-1
|
7 |
Carsten Schmelter, Kristian Nzogang Fomo, Alina Brueck, Natarajan Perumal, Sascha D. Markowitsch, Gokul Govind, Thomas Speck, Norbert Pfeiffer, Franz H. Grus. Glaucoma-Associated CDR1 Peptide Promotes RGC Survival in Retinal Explants through Molecular Interaction with Acidic Leucine Rich Nuclear Phosphoprotein 32A (ANP32A). Biomolecules 2023; 13(7): 1161 doi: 10.3390/biom13071161
|
8 |
Shanshan Wang, Yunliang Wang, Qingshan Lu, Xinshan Liu, Fuyu Wang, Xiaodong Ma, Chunping Cui, Chenghe Shi, Jinfeng Li, Dajin Zhang. The Expression and Distributions of ANP32A in the Developing Brain. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/207347
|
9 |
Patrick T. Reilly, Yun Yu, Ali Hamiche, Lishun Wang. Cracking the ANP32 whips: Important functions, unequal requirement, and hints at disease implications. BioEssays 2014; 36(11): 1062 doi: 10.1002/bies.201400058
|
10 |
Pengyue Jiang, Jing Wang, Shanli Zhu, Chao Hu, Yu Lin, Weiqing Pan. Identification of a Schistosoma japonicum MicroRNA That Suppresses Hepatoma Cell Growth and Migration by Targeting Host FZD4 Gene. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.786543
|
11 |
Yoshinori Ohno, Mitsuhito Koizumi, Hironao Nakayama, Takao Watanabe, Masashi Hirooka, Yoshio Tokumoto, Taira Kuroda, Masanori Abe, Shinji Fukuda, Shigeki Higashiyama, Teru Kumagi, Yoichi Hiasa, Yi-Hsien Hsieh. Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma. PLOS ONE 2017; 12(5): e0177343 doi: 10.1371/journal.pone.0177343
|